Lenvatinib: a potential breakthrough in advanced hepatocellular carcinoma?

Future Oncology
Georgios OikonomopoulosDebashis Sarker

Abstract

Treatment of advanced hepatocellular carcinoma (HCC) has reached a plateau after the approval of sorafenib in 2007. Several molecularly targeted therapies have failed to show significant improvement in survival outcomes compared with sorafenib, due to flaws in the design of clinical trials or failure to understand and correct for the competing co-morbidity of liver dysfunction. Lenvatinib is a multitargeted tyrosine kinase inhibitor with potent antiangiogenic effects, and has recently been approved for differentiated thyroid cancer. Lenvatinib has shown highly promising response data in Phase I/II clinical trials in HCC, although with some concerns regarding its toxicity profile. The pivotal Phase III REFLECT trial comparing lenvatinib to sorafenib has been completed, and the results of this trial will determine whether lenvatinib represents a breakthrough in the current crisis affecting HCC drug development.

References

Mar 14, 1996·The New England Journal of Medicine·V MazzaferroL Gennari
Feb 6, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Josep M LlovetUNKNOWN Barcelona-Clínic Liver Cancer Group
Oct 28, 2004·Gastroenterology·Jordi BruixJosep M Llovet
Nov 27, 2004·Endocrinology·Rosanne St BernardShereen Ezzat
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fikret SahinMichael Torbenson
Apr 16, 2005·Clinics in Liver Disease·F Xavier BoschMireia Díaz
Apr 19, 2006·Gastroenterology·Diego F CalvisiSnorri S Thorgeirsson
May 9, 2008·The New England Journal of Medicine·Robert S Kerbel
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Aug 15, 2008·Cancer Research·Derek Y ChiangJosep M Llovet
Nov 5, 2010·Molecular Cancer Research : MCR·Ellen Margrethe HaugstenJørgen Wesche
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Mar 5, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kazuhiko YamadaTomohide Tamura
Jun 30, 2011·The Biochemical Journal·Jørgen WescheEllen Margrethe Haugsten
Oct 14, 2011·The New England Journal of Medicine·Hashem B El-Serag
Jan 14, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ann-Lii ChengYoon-Koo Kang
Apr 4, 2012·Oncotarget·Melchiorre CervelloGiuseppe Montalto
May 12, 2012·The Lancet Oncology·Catherine de MartelMartyn Plummer
Oct 9, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T PressianiA Santoro
May 2, 2013·Journal of Clinical Gastroenterology·Sahil Mittal, Hashem B El-Serag
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip J JohnsonAnn-Lii Cheng
Feb 20, 2014·International Journal of Clinical Pharmacology and Therapeutics·Robert ShumakerKun Chen
Mar 25, 2014·Cancer Chemotherapy and Pharmacology·Robert C ShumakerBorje Darpo
Sep 11, 2014·Journal of Clinical Pharmacology·Robert ShumakerMin Ren
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerHans J Hammers
Dec 10, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Calin CainapSaied El-Nowiem
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Feb 12, 2015·The New England Journal of Medicine·Martin SchlumbergerSteven I Sherman
Feb 1, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T PressianiA Santoro

❮ Previous
Next ❯

Citations

Feb 24, 2016·International Journal of Clinical Oncology·Akinobu Taketomi
Apr 13, 2017·Expert Opinion on Drug Discovery·Robert Musiol
Mar 18, 2017·SLAS Technology·Ali Zarrinpar
Sep 29, 2018·Expert Opinion on Drug Safety·Masafumi IkedaShuichi Kaneko
Aug 18, 2020·International Journal of Nanomedicine·Zhong LuJin-Ming Yu
Dec 18, 2020·Seminars in Interventional Radiology·Hanna JavanNadine Abi-Jaoudeh
May 8, 2021·Virchows Archiv : an International Journal of Pathology·Marco DelsanteAvi Z Rosenberg
Sep 19, 2020·Current Topics in Medicinal Chemistry·Yanna MaoYongfang Yao

❮ Previous
Next ❯

Methods Mentioned

BETA
collection
transfection
biopsy

Software Mentioned

REFLECT

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.